Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife)
CeliaQLife
1 other identifier
observational
160
1 country
2
Brief Summary
Celiac disease is a disorder commonly diagnosed during childhood. The treatment is a lifelong gluten-free diet. Both the condition and the diet can influence the children's physical and emotional well-being. The main goal of this observational study is to learn about nutritional status in a group of children with celiac disease compared to a group of healthy children. The nutritional assessment includes information on diet, biochemical measurement, and body composition. Quality of life will also be assessed. The study can contribute to ensure good health and well-being in children on a gluten-free diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2024
CompletedStudy Start
First participant enrolled
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedAugust 23, 2024
August 1, 2024
1.4 years
August 12, 2024
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Iron deficiency will be assessed from hemoglobin and ferritin in children with celiac disease and in healthy children. Differences in the prevalences of iron deficiency between children with celiac disease and healthy children will be described.
Blood samples will be analyzed for blood hemoglobin and serum ferritin.
All participants will be assessed once. The study time frame is from August 2024 until December 2025.
Study Arms (2)
Celiac disease
Children diagnosed with celiac disease on a gluten-free diet
Healthy
Healthy children on a regular diet
Eligibility Criteria
Age: 6-18 years
You may qualify if:
- eating a regular diet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- University of Oslocollaborator
Study Sites (2)
Oslo University Hospital
Oslo, 0372, Norway
University of Oslo
Oslo, 0372, Norway
Biospecimen
Blood, urine and feces
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janne A Kvammen, Phd
Oslo University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 12, 2024
First Posted
August 23, 2024
Study Start
August 12, 2024
Primary Completion
December 20, 2025
Study Completion
December 20, 2025
Last Updated
August 23, 2024
Record last verified: 2024-08